ILÚM Health Solutions Acquires Teqqa Print E-mail
Business Wire
Thursday, 16 November 2017 03:06
Expanded IT offerings aim to support hospitals in improving outcomes for patients with infectious diseases
Read more...
 
Maryland Tech Council's Inaugural Innovation Speaker Series Event to Focus on Timely, New Innovations to Combat Opioid Crisis Print E-mail
Business Wire
Thursday, 16 November 2017 03:06
Nora D. Volkow, M.D., Director of the National Institute on Drug Abuse, National Institutes of Health, to Lead Discussion on Opioid Addiction, Prevention and Treatment
Read more...
 
Over 1,000 Multiple Brain Metastases Patients Treated with Brainlab Indication-Specific Software Print E-mail
Business Wire
Thursday, 16 November 2017 03:06
Improved Access to More Consistent Treatments with Latest Indication-Specific Technology
Read more...
 
Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell Therapy Has Been Granted Breakthrough Therapy Designation from FDA and Prime Eligibility from EMA for Relapsed and Refractory Multiple Myeloma Print E-mail
Business Wire
Thursday, 16 November 2017 03:06
Designations based on preliminary clinical data from ongoing phase I study of bb2121 in heavily pre-treated multiple myeloma
Read more...
 
Simulations Plus to Present at LD Micro 10th Annual Main Event on December 6 Print E-mail
Business Wire
Thursday, 16 November 2017 03:06
Read more...
 
Employers Face Twin Challenge in 2018 Open Enrollment; Offer More, Spend Less Print E-mail
Business Wire
Thursday, 16 November 2017 03:06
Read more...
 
New Peer-to-Peer Feedback™ Drives Employee Engagement to Improve Work Quality Print E-mail
Business Wire
Thursday, 16 November 2017 03:06
EightSpokes launches first real-time feedback loop technology to address persistent business challenge of low employee engagement while enabling ongoing work improvement
Read more...
 
Biotech Showcase™ 2018 Celebrates a Decade of Growth in the Biotech Industry Print E-mail
Business Wire
Thursday, 16 November 2017 02:06
Register now and join 3,500 biotech investors and leaders for the conference’s tenth year
Read more...
 
Biden Cancer Initiative, Michael J. Fox Foundation for Parkinson's Research, Novartis and Print E-mail
Business Wire
Thursday, 16 November 2017 02:06
Bridging Clinical Research & Clinical Health Care CollaborativeLea Studer, 402-366-1752 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
bluebird bio Announces First Patient Treated in Northstar-3 (HGB-212), Phase 3 Study of LentiGlobin™ in Patients with Transfusion-Dependent β-Thalassemia (TDT) and β0/β0 Genotype Print E-mail
Business Wire
Thursday, 16 November 2017 02:06
Read more...
 
Akebia Therapeutics to Participate in Upcoming Investor Conferences Print E-mail
Business Wire
Thursday, 16 November 2017 02:06
Akebia TherapeuticsJohn Garabo, 617-844-6130Director, Corporate Communications This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
Cue Biopharma Announces Strategic Research Collaboration and

Error. Page cannot be displayed. Please contact your service provider for more details. (32)

License Agreement with Merck
Print E-mail
Business Wire
Thursday, 16 November 2017 02:06
Agreement Focuses on Development of Next-Generation Biologics to Selectively Modulate T Cell Activity for the Treatment of Autoimmune Diseases
Read more...
 
Antibody Drug Conjugates Market 2017-2030 - Research and Markets Print E-mail
Business Wire
Thursday, 16 November 2017 02:06
Research and MarketsLaura Wood, Senior Manager This e-mail address is being protected from spambots. You need JavaScript enabled to view it For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Oncology Drugs
Read more...
 
First Clinical Data for X4P-001-RD Demonstrating Preliminary Activity in Patients with WHIM Syndrome will be Presented at American Society for Hematology Annual Meeting Print E-mail
Business Wire
Thursday, 16 November 2017 01:06
Media Contact:The Yates NetworkKathryn Morris, 914-204-6412 This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read more...
 
X4 Pharmaceuticals Secures $27 Million in Series B Financing Print E-mail
Business Wire
Thursday, 16 November 2017 01:06
Read more...
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Page 14 of 3261
BMR:1